CompoAtlas

Marron d'Inde Jambes légères BIO

Food supplement declared in France, declaration No 2023-5-1036

Marron d'Inde Jambes légères BIO (Laboratoires Vitarmonyl) is a food supplement declared in France. Status: withdrawal from the market announced for 21 August 2028. Main ingredients: Aesculus hippocastanum 250 mg per day. None of the rules we check flags an issue with its declared composition.

Brand
Laboratoires Vitarmonyl
Food business operator placing the product on the market
Laboratoires VITARMONYL
Status
Withdrawal from the market announced for 21 August 2028
Form
Capsule
Daily dose
1 gélule
Directions for use
à avaler avec un verre d'eau
Not recommended (according to the manufacturer)
Taking anticoagulants
Objectives stated by the manufacturer (these are not authorised claims)
Blood and lymphatic circulation

Declaration 194653, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Aesculus hippocastanum L.GraineExtrait sec aqueux250 mg

Other ingredients

Gélule végétale, poudre de cacao

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Regulatory points

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Aesculus hippocastanum L.
    Read the warning, when it applies and the studies cited

    Horse Chestnut - Aesculus Hippocastanum

    Route of administration: Oral (Bradley 2006; ESCOP 2003)

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Brinker 2010; Mills and Bone 2005).

    Sources cited by Health Canada (2)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.

    Known adverse reactions

    When using this product you may experience headache, dizziness, gastric irritation, or itchiness (Bradley 2006; Mills and Bone 2005; ESCOP 2003).

    Sources cited by Health Canada (3)
    • Bradley PR, editor. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 2. Bournemouth (UK): British Herbal Medicine Association; 2006.
    • ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
    • Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.

    Health Canada monograph dated 27 February 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Brand : Laboratoires Vitarmonyl

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Marron d'Inde Jambes légères BIO (Laboratoires Vitarmonyl): composition and regulation”, https://compoatlas.com/en/supplements/products/194653-marron-d-inde-jambes-legeres-bio, updated 15 November 2026.

Enter to analyse, Shift+Enter for a new line